How a compound is administered has a significant impact on how effectively it reaches its target tissues, how quickly it acts, and how much of the active compound reaches systemic circulation (bioavailability). Understanding these differences is foundational to understanding how peptides are studied.

Injectable (Subcutaneous)

Subcutaneous injection — administering a compound into the fatty tissue just beneath the skin — is the most common route for peptides in research settings. There are two primary reasons:

Bioavailability. Bypassing the digestive system ensures the peptide reaches circulation largely intact, avoiding breakdown by stomach acid and digestive enzymes.
Stability. Many peptides are fragile molecules that degrade quickly in the gastrointestinal tract. Injectable delivery protects the compound from this degradation.

Peptides commonly studied via subcutaneous injection include BPC-157, TB-500, CJC-1295, and Ipamorelin. Research protocols typically involve small-volume injections using insulin-type syringes.

Oral

Oral administration is uncommon for peptides precisely because the digestive system is designed to break down amino acid chains. Stomach acid and proteolytic enzymes cleave peptide bonds efficiently, which is useful for digesting food protein but problematic for delivering a therapeutic peptide intact to its target.

There are notable exceptions:

BPC-157 has shown unusual gastric stability in animal studies, which is why it has been studied as an oral compound for gastrointestinal conditions. The mechanism of this stability is not fully understood.
MK-677 (Ibutamoren) is technically not a peptide — it is a non-peptide growth hormone secretagogue that mimics ghrelin and is orally bioavailable. It is sometimes grouped with peptides in research communities due to its similar functional effects.

Oral peptide delivery is an active area of pharmaceutical research. Various encapsulation strategies are being studied to improve bioavailability, but most research compounds are not formulated with these protections.

Nasal (Intranasal)

Intranasal administration delivers compounds directly to the nasal mucosa, which is highly vascular and allows rapid absorption. For compounds targeting the central nervous system, the intranasal route offers an additional advantage: proximity to the olfactory epithelium, which provides a pathway to the brain that partially bypasses the blood-brain barrier.

Semax and Selank — both nootropic peptides developed in Russia — are studied and approved in Russia via the intranasal route. This approved route reflects how they were developed and studied; intranasal delivery is the route for which evidence exists for these specific compounds.

Intranasal delivery is appropriate for compounds where rapid central nervous system effects are desired, or where the nasal route offers superior bioavailability for the specific molecule.

Topical

Topical application delivers compounds directly to skin or wound surfaces. This route is appropriate for compounds intended to have local — rather than systemic — effects, as skin penetration for most peptides is limited.

Examples include:

GHK-Cu (Copper Peptide) is widely used in skincare formulations. Applied topically, it has been studied for effects on collagen synthesis, skin repair, and wound healing at the application site.
LL-37 has been studied topically for wound care and antimicrobial effects, relevant to its role as a naturally occurring antimicrobial peptide.

The systemic effects of topically applied peptides are generally minimal due to limited transdermal absorption, which can be both a limitation (for intended systemic effects) and a safety feature (for local applications).

Storage and Handling

Peptides are generally temperature-sensitive. In research settings, lyophilized (freeze-dried) peptide powder is stored refrigerated or frozen until reconstitution. Once reconstituted with bacteriostatic water, most peptides require refrigeration and have limited stability windows.

Key handling considerations that appear in research literature include:

Temperature excursions can degrade peptide structure and render compounds ineffective or potentially harmful.
Reconstitution involves adding sterile or bacteriostatic water to lyophilized powder — the volume used determines the concentration. Calculation errors lead to dosing errors.
Contamination during reconstitution or handling introduces infection risk. Sterile technique matters.
Product purity from unregulated sources varies significantly. Studies have found contaminants and mislabeled concentrations in commercially available research compounds.

Why Medical Supervision Matters

Each of the above considerations represents a category of risk that medical supervision addresses:

Dosing accuracy. A physician can calculate and prescribe appropriate doses based on your body weight, health status, and specific goals — not based on generic online protocols.
Supply quality. Compounding pharmacies that operate under medical supervision are subject to quality controls that research chemical suppliers are not.
Interaction assessment. A qualified provider can assess whether the compound you are considering interacts with medications you are taking or conditions you have.
Outcome monitoring. Regular follow-up allows identification of adverse effects early, before they become serious.

No online resource — including this one — can replace this individualized medical assessment.

Understanding Peptide Administration Routes